108 related articles for article (PubMed ID: 21232908)
1. [Flu vaccine and auto-immune and/or inflammatory diseases].
Duchet-Niedziolka P; Hanslik T; Mouthon L; Guillevin L; Launay O
Presse Med; 2011 Mar; 40(3):248-52. PubMed ID: 21232908
[TBL] [Abstract][Full Text] [Related]
2. Vaccination and auto-immune rheumatic diseases: lessons learnt from the 2009 H1N1 influenza virus vaccination campaign.
Touma Z; Gladman DD; Urowitz MB
Curr Opin Rheumatol; 2013 Mar; 25(2):164-70. PubMed ID: 23370371
[TBL] [Abstract][Full Text] [Related]
3. Immunogenicity and safety of seasonal and 2009 pandemic A/H1N1 influenza vaccines for patients with autoimmune diseases: a prospective, monocentre trial on 199 patients.
Kostianovsky A; Charles P; Alves JF; Goulet M; Pagnoux C; Le Guern V; Mouthon L; Krivine A; Villiger P; Launay O; Guillevin L;
Clin Exp Rheumatol; 2012; 30(1 Suppl 70):S83-9. PubMed ID: 22640652
[TBL] [Abstract][Full Text] [Related]
4. High disease activity: an independent factor for reduced immunogenicity of the pandemic influenza a vaccine in patients with juvenile systemic lupus erythematosus.
Campos LM; Silva CA; Aikawa NE; Jesus AA; Moraes JC; Miraglia J; Ishida MA; Bueno C; Pereira RM; Bonfa E
Arthritis Care Res (Hoboken); 2013 Jul; 65(7):1121-7. PubMed ID: 23818263
[TBL] [Abstract][Full Text] [Related]
5. Immunogenicity and safety of two doses of a non-adjuvanted influenza A H1N1/2009 vaccine in young autoimmune rheumatic diseases patients.
Aikawa NE; Trudes G; Campos LM; Pereira RM; Moraes JC; Ribeiro AC; Miraglia J; Timenetsky Mdo C; Bonfa E; Silva C
Lupus; 2013 Nov; 22(13):1394-8. PubMed ID: 24076765
[TBL] [Abstract][Full Text] [Related]
6. Autoimmune response following influenza vaccination in patients with autoimmune inflammatory rheumatic disease.
Perdan-Pirkmajer K; Thallinger GG; Snoj N; Čučnik S; Žigon P; Kveder T; Logar D; Praprotnik S; Tomšič M; Sodin-Semrl S; Ambrožič A
Lupus; 2012 Feb; 21(2):175-83. PubMed ID: 22235050
[TBL] [Abstract][Full Text] [Related]
7. Protective effect of A/H1N1 vaccination in immune-mediated disease--a prospectively controlled vaccination study.
Adler S; Krivine A; Weix J; Rozenberg F; Launay O; Huesler J; Guillevin L; Villiger PM
Rheumatology (Oxford); 2012 Apr; 51(4):695-700. PubMed ID: 22171015
[TBL] [Abstract][Full Text] [Related]
8. Immunogenicity and safety of the 2009 non-adjuvanted influenza A/H1N1 vaccine in a large cohort of autoimmune rheumatic diseases.
Saad CG; Borba EF; Aikawa NE; Silva CA; Pereira RM; Calich AL; Moraes JC; Ribeiro AC; Viana VS; Pasoto SG; Carvalho JF; França IL; Guedes LK; Shinjo SK; Sampaio-Barros PD; Caleiro MT; Goncalves CR; Fuller R; Levy-Neto M; Timenetsky Mdo C; Precioso AR; Bonfa E
Ann Rheum Dis; 2011 Jun; 70(6):1068-73. PubMed ID: 21540203
[TBL] [Abstract][Full Text] [Related]
9. Immune response to influenza vaccination in children treated with methotrexate or/and tumor necrosis factor-alpha inhibitors.
Woerner A; Sauvain MJ; Aebi C; Otth M; Bolt IB
Hum Vaccin; 2011 Dec; 7(12):1293-8. PubMed ID: 22185812
[TBL] [Abstract][Full Text] [Related]
10. INFLUENZA. Narcolepsy link to pandemic flu vaccine becomes clearer.
Vogel G
Science; 2015 Jul; 349(6243):17. PubMed ID: 26138959
[No Abstract] [Full Text] [Related]
11. Mycophenolate and lower graft function reduce the seroresponse of kidney transplant recipients to pandemic H1N1 vaccination.
Mulley WR; Visvanathan K; Hurt AC; Brown FG; Polkinghorne KR; Mastorakos T; Lewicki MC; Stuart RL; Tan SJ; Chean R; Kerr PG; Kanellis J
Kidney Int; 2012 Jul; 82(2):212-9. PubMed ID: 22495292
[TBL] [Abstract][Full Text] [Related]
12. Pandemic influenza A H1N1 vaccine in recipients of solid organ transplants: immunogenicity and tolerability outcomes after vero cell derived, non-adjuvanted, whole-virion vaccination.
Lagler H; Wenisch JM; Tobudic S; Gualdoni GA; Rödler S; Rasoul-Rockenschaub S; Jaksch P; Redlberger-Fritz M; Popow-Kraupp T; Burgmann H
Vaccine; 2011 Sep; 29(40):6888-93. PubMed ID: 21803100
[TBL] [Abstract][Full Text] [Related]
13. Improved serological response to H1N1 monovalent vaccine associated with viral suppression among HIV-1-infected patients during the 2009 influenza (H1N1) pandemic in the Southern Hemisphere.
Maruszak H; Jeganathan S; Smith DE; Robertson P; Barnes T; Furner V
HIV Med; 2012 Jul; 13(6):352-7. PubMed ID: 22296264
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of pandemic H1N1 (2009) influenza vaccine in adults with solid tumor and hematological malignancies on active systemic treatment.
Mackay HJ; McGee J; Villa D; Gubbay JB; Tinker LM; Shi L; Kuruvilla J; Wang L; MacAlpine K; Oza AM
J Clin Virol; 2011 Mar; 50(3):212-6. PubMed ID: 21168361
[TBL] [Abstract][Full Text] [Related]
15. How should we best manage patients with immune-mediated inflammatory disease on immunosuppressant therapy during the 'swine flu' pandemic?
Mangat P; Abraham S
QJM; 2011 Mar; 104(3):269-70. PubMed ID: 20843774
[No Abstract] [Full Text] [Related]
16. Immunogenicity and tolerability of inactivated flu vaccine in high risk and healthy children.
Avila Aguero ML; Soriano-Fallas A; Umaña-Sauma MA; Ulloa-Gutierrez R; Arnoux S
Medicina (B Aires); 2007; 67(4):351-9. PubMed ID: 17891930
[TBL] [Abstract][Full Text] [Related]
17. Serologic response after vaccination against influenza (A/H1N1)pdm09 in children with renal disease receiving oral immunosuppressive drugs.
Tanaka S; Saikusa T; Katafuchi Y; Ushijima K; Ohtsu Y; Tsumura N; Ito Y
Vaccine; 2015 Sep; 33(38):5000-4. PubMed ID: 26083312
[TBL] [Abstract][Full Text] [Related]
18. A/H1N1 antibodies and TRIB2 autoantibodies in narcolepsy patients diagnosed in conjunction with the Pandemrix vaccination campaign in Sweden 2009-2010.
Lind A; Ramelius A; Olsson T; Arnheim-Dahlström L; Lamb F; Khademi M; Ambati A; Maeurer M; Nilsson AL; Bomfim IL; Fink K; Lernmark Å
J Autoimmun; 2014 May; 50():99-106. PubMed ID: 24485154
[TBL] [Abstract][Full Text] [Related]
19. H1N1 vaccination in pediatric renal transplant patients.
Kelen K; Ferenczi D; Jankovics I; Varga M; Molnar MZ; Sallay P; Reusz G; Langer RM; Pasti K; Gerlei Z; Szabo AJ
Transplant Proc; 2011 May; 43(4):1244-6. PubMed ID: 21620100
[TBL] [Abstract][Full Text] [Related]
20. Antibody response to the non-adjuvanted and adjuvanted influenza A H1N1/09 monovalent vaccines in renal transplant recipients.
Salles MJ; Sens YA; Malafronte P; Souza JF; Vilas Boas LS; Machado CM
Transpl Infect Dis; 2012 Dec; 14(6):564-74. PubMed ID: 22882692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
